Back to Results
First PageMeta Content
Biotechnology / Prostate cancer / Prostate-specific antigen / Prostate / Cancer / Minimal residual disease / PCA3 / Prostate cancer screening / Medicine / Biomarkers / Tumor markers


ClinChem200905_Bruns-glucose
Add to Reading List

Document Date: 2015-01-13 16:08:30

Open Document

File Size: 64,16 KB

Share Result on Facebook

City

Nashville / Göttingen / /

Company

Chronix Biomedical / Molecular Diagnostics / /

Country

Germany / United States / /

Facility

Vanderbilt University / Laboratory Medicine / Boston Children’s Hospital / /

IndustryTerm

specific cancer treatment / healthcare / /

MedicalCondition

cancers / low risk breast cancer / common cancer / minimal residual disease / cancer / disease / colorectal cancers / cell-free tumor DNA / ASCO cancer / specific cancer / neck cancers / Prostate Cancer / head cancers / breast cancer / pancreatic cancer / /

MedicalTreatment

surgery / radiation / /

Organization

Boston Children’s Hospital / Department of Laboratory Medicine / American Association for Clinical Chemistry Page / Department of Pathology / Microbiology / and Immunology / Vanderbilt University / Department of Pathology / Microbiology / and Immunology at Vanderbilt University / /

Person

Bob Barrett / William Mitchell / Howard Urnovitz / /

Position

CEO / Professor / /

Product

fluorouracil / /

ProvinceOrState

Tennessee / /

Technology

genomics / radiation / cell-free DNA technologies / human genome / /

URL

http /

SocialTag